Replies to post #465572 on Anavex Life Sciences Corp (AVXL)

[Doc328]

I think he wants to keep 150 MM cash on hands to always have at least 2 years funding to avoid being desperate during a SP or general economic downturn. It is probably a good idea to always have a shelf available. I don't know when previous arrangements expire. He is a better CFO than CEO. I don't expect any regulatory filings until 2027 or later.

https://ih.advfn.com/stock-market/NASDAQ/anavex-life-sciences-AVXL/stock-news/94270327/form-s-3-registration-statement-under-securities

[crescentmotor]

Why capital raise at $6 when EMA filing is with 5 months?

Hopefully, Missling is not contemplating a stock issuance in the near term. If that happens, Missling will be on my permanent shat list.

[ignatiusrielly35]

Maybe a BP wants to partner and simultaneously take an equity stake in the company. Maybe institutional investors have complained that they can’t find sizable volumes of shares because so many are held by retail. Maybe Missling is just playing it safe.

[kund]

It's just the registration, but I wouldn't be surprised if they actually dilute this week. There will likely be one more pump before that happens; this pattern is common with many small biotech companies, and Anavex is no different.

Never trust management completely—they often say one thing and do another 99% of the time.

[Investor2014]

To have financing for the inevitable confirmatory P3 trials for AD and Rett plus the other indications that still haven’t gone anywhere.

[Steady_T]

If you read the filing it says that an additional prospectus will be filed before any share sales. This is the preliminary document.

[boi568]

From what I have seen from Missling's financial moves, he is more long term and strategic rather than short term and tactical. He may be increasing capacity to self fund major indications, or at least is arranging that card for potential negotiations with partners or acquirers. There is certainly no immediate need for this level of cash, and no need to dilute at the current share price.

[pcguy]

Just the same BS with this company. The same BS as the people that will claim it provides a "strong" financial position for partnering discussions. It is no wonder this company is valued where it is. The same BS claims were made the last time and guess what, none of the claims came true, only dilution. Same for the people that claimed the shelf wouldn't be used. Well we're here again, and I have no reason to believe that dilution won't occur at break neck speeds with pending "news" and low price.

[mrplmer]

his conversations with potential BP licensees obviously isn't going well. Chess move. More outstanding stock.